Abstract:Purpose: To investigate whether short-term, intensive lipid therapy leads to changes in microvascular characteristics, as measured by using dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging.Materials and Methods: Institutional review board approval and informed consent were obtained for this HIPAA-compatible study. Subjects with established coronary artery disease or carotid artery stenosis of 15% or greater determined by using ultrasonography and with levels of apolipoprotein B of 120 mg/dL (1.2 g/L) or greater were enrolled in an ongoing study (clinical trial NCT00715273). All received intensive lipid therapy to achieve targeted high-and low-density lipoprotein cholesterol levels and underwent serial serum monitoring including high-sensitivity C-reactive protein (HsCRP) level measurements. Carotid artery MR imaging examinations including morphologic and DCE MR images were obtained at baseline and 1 year after treatment. In subjects with advanced lesions (>2 mm thick), MR image analysis was performed, including measurement of lipid-rich necrotic core size and kinetic modeling of DCE MR images to assess changes in the transfer constant (K-trans). The differences in K-trans between baseline and 1-year follow-up were compared by using the Wilcoxon signed rank test, and associations were assessed by using the Spearman rank correlation coefficient.Results: Twenty-eight subjects with interpretable DCE MR imaging results at both baseline and 1-year follow-up were included. After 1 year of treatment, a significant reduction was found in mean K-trans (0.085 min(-1) +/- 0.037 [standard deviation] to 0.067 min(-1) +/- 0.028, P = .02). Reduction in K-trans was not significantly correlated with observed reductions in lipid-rich necrotic core size or reductions in HsCRP level.Conclusion: These findings suggest that DCE MR imaging may be a useful imaging method for the assessment of the therapeutic response of the vasa vasorum in patients with atherosclerotic plaque.

Lipidomics In Carotid Artery Stenosis: Further Understanding Of Pathology And Treatment

Effect of Lipitor on the Biomechanics of Carotid Atherosclerotic Plaques by Velocity Vecto Imaging

New Technologies in the Assessment of Carotid Stenosis: Beyond the Color-Doppler Ultrasound—High Frame Rate Vector-Flow and 3D Arterial Analysis Ultrasound

Omics Science and Social Aspects in Detecting Biomarkers for Diagnosis, Risk Prediction, and Outcomes of Carotid Stenosis

Clinical Lipidomics: A Critical Approach For Disease Diagnosis And Therapy

Recent advances in lipidomics for disease research

Relationship between Plasma Lipidomics and Carotid Atherosclerotic Plaque

Non-invasive monitoring and classification of coronary heart disease by metabolomics and lipidomics

Abstract T P86: Lipid Profiling Reveals Galatosylceramide Increasing in Plasma of Atherosclerotic Stroke

Imaging of Carotid Stenosis: Where Are We Standing? Comparison of Multiparametric Ultrasound, CT Angiography, and MRI Angiography, with Recent Developments

Carotid Artery Atherosclerosis: Effect Of Intensive Lipid Therapy On The Vasa Vasorum-Evaluation By Using Dynamic Contrast-Enhanced Mr Imaging

Lipidomics applications for discovering biomarkers of diseases in clinical chemistry

Lipid-related radiomics of low-echo carotid plaques is associated with diabetic stroke and non-diabetic coronary heart disease

Bridging the gap for lipid lowering therapy: plaque regression, coronary computed tomographic angiography, and imaging-guided personalized medicine

Application of Lipidomics in the Study of Traditional Chinese Medicine

Quantifying Carotid Stenosis: History, Current Applications, Limitations, and Potential: How Imaging Is Changing the Scenario

Recent advances in analytical strategies for mass spectrometry-based lipidomics

Liposome technology for cardiovascular disease treatment and diagnosis

High-resolution magnetic resonance vessel wall imaging in ischemic stroke and carotid artery atherosclerotic stenosis: A review

[Research progress of lipid-derived parameters in atherosclerotic cardiovascular disease]

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development